uniQure (QURE) Profit After Tax (2016 - 2026)
uniQure (QURE) recorded quarterly Profit After Tax of -$53.5 million in Q1 2026, down 44.35% quarter-over-quarter from -$37.1 million in Q4 2025, and down 22.68% on a YoY basis from -$69.2 million in Q1 2025.
uniQure (QURE) Profit After Tax (2016 - 2026) Analysis & Trends
uniQure's Profit After Tax history runs 11 years deep, the most recent figure standing at -$53.5 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 22.68% year-over-year to -$53.5 million; the TTM figure through Mar 2026 stood at -$208.9 million (up 4.0% YoY), while the FY2025 annual figure was -$199.0 million, up 16.94% from the prior year.
- Profit After Tax was -$53.5 million for Q1 2026 at uniQure, down from -$37.1 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $6.8 million in Q4 2022 to a low of -$89.6 million in Q3 2023.
- Historically, Profit After Tax has averaged -$54.5 million across 5 years, with a median of -$53.5 million in 2026.
- The sharpest annual moves came in 2023 and 2024: Profit After Tax sank 1175.45% in 2023, then surged 50.45% in 2024.
- A 5-year view of Profit After Tax shows it stood at $6.8 million in 2022, then tumbled by 1175.45% to -$73.2 million in 2023, then dropped by 0.08% to -$73.3 million in 2024, then soared by 49.38% to -$37.1 million in 2025, then tumbled by 44.35% to -$53.5 million in 2026.
- The last three Profit After Tax figures came in at -$53.5 million (Q1 2026), -$37.1 million (Q4 2025), and -$80.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | -53.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.54 Mn |
| Dec 31, 2025 | -37.09 Mn |
| Sep 30, 2025 | -80.53 Mn |
| Jun 30, 2025 | -37.72 Mn |
| Mar 31, 2025 | -43.64 Mn |
| Dec 31, 2024 | -73.26 Mn |
| Sep 30, 2024 | -44.38 Mn |
| Jun 30, 2024 | -56.30 Mn |
| Mar 31, 2024 | -65.62 Mn |
| Dec 31, 2023 | -73.21 Mn |
| Sep 30, 2023 | -89.57 Mn |
| Jun 30, 2023 | -68.47 Mn |
| Mar 31, 2023 | -77.23 Mn |
| Dec 31, 2022 | 6.81 Mn |
| Sep 30, 2022 | -47.86 Mn |
| Jun 30, 2022 | -39.06 Mn |
| Mar 31, 2022 | -46.68 Mn |
| Dec 31, 2021 | 11.42 Mn |
| Sep 30, 2021 | -36.53 Mn |
| Jun 30, 2021 | 399.47 Mn |